Efficacy and safety of octanorm (cutaquig® ) in adults with primary immunodeficiencies with predominant antibody deficiency: a prospective, open-label study.
- Resource Type
- Article
- Source
- Immunotherapy (1750743X); Apr2020, Vol. 12 Issue 5, p299-309, 11p
- Subject
- Language
- ISSN
- 1750743X